Abstract
Sclerosing polidocanol injections targeting the area with vasculo/neural ingrowth on the ventral side of the tendon have previously been demonstrated to give good clinical results in patients with chronic painful midportion Achilles tendinosis. In this study, 20 consecutive patients (9 men and 11 women, mean age 46 years) with chronic painful midportion Achilles tendinosis were treated with either sclerosing polidocanol injections (Group A) or open surgical revision of the area with vasculo/neural ingrowth on the ventral side of the Achilles tendon (Group B). Before treatment, all patients had structural tendon changes and increased blood flow-neovascularisation demonstrated with US and colour Doppler. Under US and colour Doppler-guidance, both the injections and the surgical revision targeted the area with neovessels just outside the ventral part of the tendon. A maximum of two sclerosing injection treatments, with 6–8 weeks in-between, were given. For evaluation, the patients recorded the severity of Achilles tendon pain during tendon loading activity (their recreational or sport activity), before and after treatment, on a VAS. Patient global satisfaction with treatment was also assessed. At the 3 months follow-up 6/9 (one patient was excluded) patients in Group A, and 8/10 patients in Group B, were satisfied with the treatment and had a significantly reduced level of tendon pain (Group A VAS from 76 to 24, P < 0.05, Group B VAS from 75 to 21, P < 0.05). There was one deep infection in Group B. At the 6 months follow-up, 6/9 patients in Group A, and 10/10 patients in Group B were satisfied. In summary, both treatment with sclerosing polidocanol injections and open surgical revision outside the ventral Achilles midportion show promising short-term clinical results.
Similar content being viewed by others
References
Öhberg L, Lorentzon R, Alfredson H (2001) Neovsacularisation in Achilles tendons with painful tendinosis but not in normal tendons: an ultrasonographic investigation. Knee Surg Sports Traumatol Arthrosc 9:233–238
Alfredson H, Öhberg L, Forsgren S (2003) Is vasculo-neural ingrowth the cause of pain in chronic Achilles tendinosis? An investigation using ultrasonogrphy and colour Doppler, immunohistochemistry, and diagnostic injections. Knee Surg Sports Traumatol Arthrosc 11:334–338
Bjur D, Alfredson H, Forsgren S (2005) The innervation pattern of the human Achilles tendon. Studies on the normal and tendinosis tendon using markers for general, sensory and sympathetic innervations. Cell Tissue Res 320:201–206
Öhberg L, Alfredson H (2002) Ultrasound guided sclerosing of neovessels in painful chronic Achilles tendinosis: pilot study of a new treatment. Br J Sports Med 36:173–177
Alfredson H, Öhberg L (2005) Sclerosing injections to areas of neovascularisation reduce pain in chronic Achilles tendinopathy: a double-blind randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 13:338–344
Lind B, Öhberg L, Alfredson H (2006) Sclerosing polidocanol injections in mid-portion Achilles tendinosis: remaining good clinical results and decreased tendon thickness at 2-year follow-up. Knee Surg Sport Traumatol Arthrosc 14:1327–1332
Kvist M (1994) Achilles tendon injuries in athletes. Sports Med 18(3):173–201
Åström M (1997) On the nature and etiology of chronic Achilles tendinopathy. Dissertation, University of Lund, Lund
Alfredson H, Lorentzon R (2000) Chronic Achilles Tendinosis: recommendations for treatment and prevention. A review. Sports Med 29(2):135–146
Alfredson H, Pietilä T, Öhberg L et al (1998) Achilles tendinosis and calf musclle strength. The effect of short-term immobilization after surgical treatment. Am J Sports Med 26(2):166–171
Maffuli N, Testa V, Capasso G, Bifulco G, Binfield P (1997) Results of percutaneous longitudinal tenotomy for Achilles tendinopathy in middle- and long-distance runners. Am J Sports Med 25(6):835–840
Tallon C, Coleman B D, Khan K M, Maffulli N (2001) Outcome of surgery for chronic Achilles tendinopathy. A critical review. Am J Sports Med 29:315–320
Conrad P, Malouf GM, Stacey MC (1995) The Australian polidocanol (aethoxysklerol) study. Results at 2 years. Dermatol Surg 21(4):334–336
Guex JJ (1993) Indications for the sclerosing agent polidocanol. J Dermatol Surg Oncol 19(10):959–961
Andersson G, Danielsson P, Alfredson H, Forsgren S (2006) The arteries in the area targeted with successful sclerosing injections for Achilles tendinosis are under distinct neural control. In: Abstract 10th international conference on orthopaedics, biomechanics, and sports rehabilitation, Assisi, Italy
Alfredson H, Öhberg L (2006) Increased intratendinous vascularity in the early period after sclerosing injection treatment in Achilles tendinosis. A healing response? Knee Surg Sports Traumatol Athrosc 14:399–401
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alfredson, H., Öhberg, L., Zeisig, E. et al. Treatment of midportion Achilles tendinosis: similar clinical results with US and CD-guided surgery outside the tendon and sclerosing polidocanol injections. Knee Surg Sports Traumatol Arthr 15, 1504–1509 (2007). https://doi.org/10.1007/s00167-007-0415-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00167-007-0415-8